Hard Medicine
Cancer care still mostly revolves around one goal: chasing cure. But what if that approach is costing us thousands of lives and untold suffering? In this episode of Hard Medicine, Dr. Yurkiewicz speaks with Dr. Azra Raza, oncologist and author of The First Cell [https://azraraza.com/books/the-first-cell/], about why cancer medicine still prioritizes treatment over prevention — and the paradigm shift needed to change that. They discuss what stands in the way: massive disparities in research funding, a health care system that flattens prevention into one-size-fits-all, and a medical culture favoring incremental advances over radical change. They also explore solutions, from targeting cancer precursors in the bloodstream to tailored screening for people at high risk. This is a conversation about cancer that is both deeply critical and optimistic. 0:06 Opening Monologue: From Treatment to Prevention — Cancer Needs a Paradigm Shift 2:49 Why Focus on Prevention? 8:33 Cancer Is Too Complex to Cure 14:45 95% of Cancer Drug Research Fails 18:47 What’s Wrong With Mouse Models? 27:40 Building Biobanks From Human Samples 30:18 The “Stentinel” 37:21 The Limits of One-Size-Fits-All Screening 44:43 Rapid Fire Q&A: Blood Tests for Early Detection, Full-Body MRIs, and Rising Cancers in Young Adults 50:31 Is Cancer Preventable? Get full access to Hard Medicine at ilanayurkiewiczmd.substack.com/subscribe [https://ilanayurkiewiczmd.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]
6 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Hard Medicine!